Mr. Speaker, I as well listened to the Minister of Industry's speech, the general drift of which was that we should just let Bill S-17 pass and there would be ample opportunity in the future for us to revisit the whole idea of lengthy patent protection and some sort of domestic pharmaceutical policy.
Does the member for Burnaby—Douglas believe that we still have the domestic ability to negotiate these things or have trade agreements limited our ability to have a domestic policy in that regard?